Statutory Committee inquiries
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9am on Monday 22, Tuesday 23, Wednesday 24 and Thursday 25 October 2007 to hear the following inquiries:
1. The committee will hear the new inquiry into a complaint by the Council
of the Society against Viviane Andraous (registration number 1078359)
which alleges that taking £2,000 cash, found in a box of patient-returned
medicine, home; failing to inform staff at the pharmacy of the location
of the cash; failing to tell staff at the pharmacy that she had taken
possession of the cash and/or taken it home; failing to take adequate
steps to identify and/or contact the owner of the cash; failing to inform
her employer of the discovery of the cash; failing to ensure the cash
was kept in a safe location; failing to notify anyone that she knew where
the cash was when a formal investigation was being carried out; and failing
to disclose, when interviewed, that she had been dismissed from the pharmacy
for gross misconduct, may amount to misconduct.
2. The committee will hear the new inquiry into a complaint by the Council
of the Society against John Joseph George Barnes (registration
number 62087) which alleges that a failure to make entries in the Controlled
Drugs registers in contravention of Regulation 19 of the Misuse of Drugs
Regulations 2001 and Key Responsibility 3 of the Code of Ethics and Standards,
may amount to misconduct.
3. The committee will resume the inquiry into a complaint by the Council
of the Society against Shiv Kumar Sharma (registration number 90720)
which alleges that conduct contrary to: Part 2 A.1(a) of the Code of
Ethics and Standards, in that he did not have the requisite fitness for
the tasks to be performed; Key Responsibility 1 of the Code of Ethics
and Standards, in that he did not at all times act in the interests of
patients and other members of the public; Key Responsibility 2 of the
Code of Ethics and Standards, in that he failed to ensure his performance
was of a high quality; and Key Responsibility 3 of the Code of Ethics
and Standards, in that he failed to adhere to accepted standards of personal
and professional conduct and engaged in behaviour or activity likely
to bring the profession into disrepute or undermine public confidence
in the profession, may amount to misconduct.
4. The committee will hear the new inquiry into a complaint by the Council
of the Society against Girish Balvantrai Desai (registration number 66679)
and Lemongold Ltd (identification number 1002073) which alleges that
the supply of metformin 500mg tablets at a dose of one tablet twice daily
without the authority of a prescription; the supply of gliclazide 80mg
tablets at a dose of one in the morning and two at night against a prescription
calling for gliclazide 80mg tablets at a dose of one in the morning;
the supply of four Dosette boxes which were not labelled to indicate
(a) the name and address of supplier; (b) date on which product was dispensed;
(c) name of product supplied; (d) directions for use; (e) precautions
relating to use; and (f) name of patient (in relation to three of the
four Dosette boxes); erroneously informing a daughter of a patient that
a prescription had not changed from previous prescriptions in answer
to a query; failing to check the prescription before answering the above
query; failing to provide patient information leaflets to patients unless
a patient specifically asked for one; failing to provide a PIL if a patient
received new medicine in a Dosette box, may amount to misconduct.
Fitness to Practise Committees Secretariat
|
The
Pharmaceutical Journal